share_log

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%), etc.

Amylyx Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%)等

美股SEC公告 ·  08/26 18:51
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息